05-02-2011 01:51 PM CET - Health & Medicine
Print PDF Email

The intelligent symbiosis of robotic, traditional and single port interventions in MIC

Press release from: Tuebingen Scientific Medical GmbH

Tübingen, May 3, 2011 – Tuebingen Scientific Medical GmbH, producer of deflectable, laparoscopic instruments, presents the new radius r2 SERIES at the Congress of the German Society of Surgery.

The various minimally invasive procedures offer advantages as well as disadvantages for surgeons and for patients.
A new concept combines several benefits of the individual procedures and therefore offers a decisive value add.

The degrees of freedom and precision of robotic surgery combined with
• the flexibility of instrument choice, access positioning, patient position and definition of inclusion criteria of traditional laparoscopy
• operating directly on the patient as opposed to remotely from a console
• single port surgery
• cost-effective standard settings of traditional laparoscopy
• short preparation times
• the elimination of investment and maintenance costs

Single port surgery combined with
• the degrees of freedom and precision offered by robotic surgery
• the freedom of traditional laparoscopy
• the elimination of classical single port challenges:
o the crossing of instruments and therefore mirrored view
o mutual hindrance of instruments due to „sword fighting“, i.e. the instruments hinder each other by crossing over
o limited freedom of movement of straight and pre-formed instruments

Traditional laparoscopy combined with
• the degrees of freedom and flexibility of robotic operating
• highest precision even in difficult angles and anatomically tight spaces

The radius r2 SERIES includes two complementary lines: r2 DRIVE and r2 CURVE. The laparoscopic surgeon is thus equipped with instruments that optimally support him with the degrees of freedom normally offered by robotic systems in traditional laparoscopic interventions as well as in single port surgery.

r2 DRIVE has been CE certified and is thus available for clinical use. The second version r2 CURVE will be released in the next months.

r2 DRIVE – for laparascopic surgery

r2 DRIVE is hand-held instrument that offers all degrees of freedom of a robotic system. A distinctive feature is the flexibility of the sequence of movements. Due to the 90°-deflectable and rotatable tip, in combination with the rotatable shaft, surgical maneuvers can be confidently and precisely carried out even in difficult angles and tight spaces.
The unique operating concept of the instrument enables surgical intervention in areas that would otherwise be inaccessible. The instrument is primarily controlled with the fingertips, thereby offering utmost precision and total comfort for the surgeon. Extensive movements are thus rendered superfluous, which obviates fatigue and discomfort on the part of the surgeon.
The shaft diameter is 5 mm, enabling body access through small incisions.
Bipolar HF-technology provides secure, reproducible and clearly defined effects in preparation and hemostasis.
The instrument will be available in various configurations: atraumatic forceps, needle holder, dissector and scissors. In this way, different operative manipulations can be carried out in various medical disciplines.
The radius r2 is a disposable, one-piece instrument without time-consuming assembly or recycling.

Tuebingen Scientific:
Tuebingen Scientific Medical GmbH develops innovative surgical instruments with a clear focus on an optimal cost : benefit ratio. Our goal is to produce innovative technologies which create a significant value add for medical personnel and patients and which are—with respect to application and price structure—suitable for daily use in hospitals. Tuebingen Scientific was founded by experts who have extensive knowledge of technology development and minimally invasive surgical procedures. Today the company is run by a team of experts with extensive technical, clinical and marketing knowledge and skills. For more information please visit www.tuebingen-scientific.com.

Tuebingen Scientific Medical GmbH
Mrs. Heike Debaets
Sales and Marketing Director
Dorfackerstr. 26
72074 Tübingen
Germany
Tel.: + 49 7071 98979 140
Fax: + 49 7071 98979 240
e-mail: pr@tuebingen-scientific.com
www.tuebingen-scientific.com

This release was published on openPR.
News-ID: 173256
del.icio.us:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine MisterWong:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine Digg:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine StumbleUpon:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine Technorati:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine Reddit:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine Furl:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine WebNews:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine OneView:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine LinkArena:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine YiGG:The intelligent symbiosis of robotic, traditional and single port interventions in MIC - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.